# Dual-Phase Immunomodulation by the Bovine β-Casein Peptide KEMPFPK: Insights into Potential TLR Interaction and Gut Microbiota-Mediated Effects

**Authors:** Junpeng Zhang, Xinyu Zhang, Jianping Wu, Guangqing Mu, Xiaomeng Wu

PMC · DOI: 10.3390/foods15061080 · 2026-03-19

## TL;DR

This study shows that the KEMPFPK peptide from cow milk can modulate the immune system and gut bacteria, offering potential for functional foods.

## Contribution

The study reveals KEMPFPK's dual-phase immunomodulation via TLR interaction and gut microbiota modulation.

## Key findings

- KEMPFPK enhances macrophage activity and reduces inflammation via NF-κB and MAPK inhibition.
- KEMPFPK binds to TLR2 and TLR4, suggesting a direct mechanism for immune modulation.
- KEMPFPK restores immune function in mice and reshapes gut microbiota by promoting beneficial bacteria.

## Abstract

This study investigates the immunomodulatory effects and underlying mechanisms of KEMPFPK, a peptide derived from bovine β-casein, using integrated in vitro, in silico, and in vivo approaches. In RAW264.7 macrophages, KEMPFPK enhanced proliferation, phagocytosis, and migration and selectively upregulated the chemokine MCP-1. Under LPS-induced inflammation, KEMPFPK suppressed pro-inflammatory cytokines (IL-1β, TNF-α) and NO production while promoting the anti-inflammatory cytokine IL-10. These effects were mediated through the inhibition of NF-κB and MAPK signaling pathways. Molecular docking predicted high-affinity binding of KEMPFPK to Toll-like receptors (TLR2 and TLR4), suggesting a potential mechanism for its immunomodulatory activity. In cyclophosphamide (CTX)-induced immunosuppressed mice, KEMPFPK administration restored immune organ indices, rebalanced serum cytokine levels, and modulated humoral immunity. Importantly, KEMPFPK was associated with a significantly reshaped gut microbiota profile, characterized by the promotion of beneficial genera (e.g., Ligilactobacillus, Adlercreutzia) and the suppression of opportunistic pathogens (e.g., Escherichia–Shigella). These findings establish KEMPFPK as a dual-phase immunomodulator and suggest that its effects may involve direct immune cell regulation coupled with indirect microbiota remodeling. This study provides a scientific foundation for the application of KEMPFPK in immunomodulatory functional foods.

## Linked entities

- **Proteins:** CCL2 (C-C motif chemokine ligand 2), IL1B (interleukin 1 beta), TNF (tumor necrosis factor), IL10 (interleukin 10), NFKB1 (nuclear factor kappa B subunit 1), MAPK (mitogen activated kinase-like protein), TLR2 (toll like receptor 2), TLR4 (toll like receptor 4)
- **Chemicals:** NO (PubChem CID 24822), cyclophosphamide (PubChem CID 2907)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 281246] {aka IF2A}, TNF (tumor necrosis factor) [NCBI Gene 280943] {aka TNF-a, TNF-alpha, TNFa}, CCL2 (chemokine (C-C motif) ligand 2) [NCBI Gene 281043] {aka MCP-1, MCP-1A, MCP1, MCP1A, SCYA2}, CSN2 (casein beta) [NCBI Gene 281099], IL1B (interleukin 1 beta) [NCBI Gene 281251], TLR4 (toll like receptor 4) [NCBI Gene 281536], TLR2 (toll like receptor 2) [NCBI Gene 281534]
- **Diseases:** inflammation (MESH:D007249)
- **Chemicals:** KEMPFPK (-), CTX (MESH:D003520), LPS (MESH:D008070), NO (MESH:D009614)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090], Shigella (genus) [taxon 620], Escherichia coli (E. coli, species) [taxon 562]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025458/full.md

---
Source: https://tomesphere.com/paper/PMC13025458